An update: vitamin E supplementation and heart disease

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Nutritional Science

Background:

• Oxidation of low-density lipoprotein (LDL) and oxidative stress are implicated in atherogenesis.
• Antioxidants, such as vitamin E, were hypothesized to prevent or reverse atherosclerosis.
• Clinical trials on vitamin E for cardiovascular disease (CVD) have yielded inconsistent outcomes.

Purpose of the Study:

• To review the evidence linking LDL oxidation to atherosclerosis.
• To analyze the mixed results of vitamin E clinical trials in CVD patients.
• To propose new research directions and inform current patient recommendations.

Main Methods:

• Review of in vitro and animal model studies on LDL oxidation.
• Analysis of clinical trial data for vitamin E interventions in CVD.
• Synthesis of findings regarding antioxidant actions and CVD outcomes.

Main Results:

• Strong evidence supports LDL oxidation's role in atherosclerosis initiation and progression.
• Vitamin E, a primary dietary antioxidant, showed varied effects in CVD patients, including no benefit or adverse impacts.
• Inconsistencies highlight the complexity of antioxidant roles in cardiovascular health.

Conclusions:

• The role of antioxidants like vitamin E in CVD requires further investigation.
• Current clinical trial results challenge simple antioxidant supplementation strategies for atherosclerosis.
• New study designs are needed to clarify antioxidant efficacy and guide patient advice for cardiovascular health.